 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/16/2024 |
$0.06 |
$0.06 |
$0.06 |
$0.06 |
300 | | 04/17/2024 |
$0.07 |
$0.07 |
$0.07 |
$0.07 |
500 | | 04/18/2024 |
$0.07 |
$0.07 |
$0.07 |
$0.07 |
0 | | 04/19/2024 |
$0.07 |
$0.07 |
$0.07 |
$0.07 |
0 | | 04/22/2024 |
$0.07 |
$0.07 |
$0.07 |
$0.07 |
0 |
|
|
| Enzon Pharmaceuticals receives royalty revenues from existing licensing arrangements with other companies primarily related to sales of four marketed drug products, namely, PegIntron®, Sylatron®, Macugen® and CIMZIA®. PegIntron® is used for the treatment of chronic hepatitis C. Sylatron® is used for the treatment of melanoma. Macugen® is used for the treatment of neovascular (wet) age-related macular degeneration. CIMZIA® is used for the treatment of Crohn's disease and rheumatoid arthritis. Co. has no clinical operations and limited corporate operations. | |
|
ENZN (ENZN) has the following price history information. Looking back at ENZN historical stock prices for the last five trading days, on April 16, 2024, ENZN opened at $0.06, traded as high as $0.06 and as low as $0.06, and closed at $0.06. Trading volume was a total of 300 shares. On April 17, 2024, ENZN opened at $0.07, traded as high as $0.07 and as low as $0.07, and closed at $0.07. Trading volume was a total of 500 shares. On April 18, 2024, ENZN opened at $0.07, traded as high as $0.07 and as low as $0.07, and closed at $0.07. Trading volume was a total of 0 shares. On April 19, 2024, ENZN opened at $0.07, traded as high as $0.07 and as low as $0.07, and closed at $0.07. Trading volume was a total of 0 shares. On April 22, 2024, ENZN opened at $0.07, traded as high as $0.07 and as low as $0.07, and closed at $0.07. Trading volume was a total of 0 shares.
ENZN Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into ENZN shares, starting with a $10,000 purchase of ENZN, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
04/24/2014 |
|
| End date: |
04/22/2024 |
|
| Start price/share: |
$1.00 |
|
| End price/share: |
$0.07 |
|
| Starting shares: |
10,000.00 |
|
| Ending shares: |
90,917.85 |
|
| Dividends reinvested/share: |
$1.33 |
|
| Total return: |
-36.36% |
|
| Average Annual Total Return: |
-4.42% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$6,362.33 |
|
| Years: |
10.00 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/24/2014 |
|
| End date: |
04/22/2024 |
|
| Start price/share: |
$1.00 |
|
| End price/share: |
$0.07 |
|
| Dividends collected/share: |
$1.33 |
|
| Total return: |
40.00% |
|
| Average Annual Total Return: |
3.42% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$13,998.62 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/16/2024 | $0.06 | | 04/17/2024 | $0.07 | | 04/18/2024 | $0.07 | | 04/19/2024 | $0.07 | | 04/22/2024 | $0.07 |
|
|
Free ENZN Email Alerts:
